Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Olaparib With Ceralasertib in Recurrent Osteosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE4
Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients
- Status
- TERMINATED
- Phase
- N/A
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831
- Status
- COMPLETED
- Phase
- PHASE1
Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
- Status
- UNKNOWN
- Phase
- N/A
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.
- Status
- TERMINATED
- Phase
- PHASE4
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
- Status
- COMPLETED
- Phase
- PHASE2
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
- Status
- RECRUITING
- Phase
- PHASE2
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
- Status
- COMPLETED
- Phase
- PHASE4